COMPOSITE RESPONDERS SHOWED IMPROVEMENT IN BOTH PENILE CURVATURE DEFORMITY AND SYMPTOM BOTHER IN TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF PEYRONIE'S DISEASE

被引：0
|
作者：
Hellstrom, Wayne
Feldman, Robert
Smith, Ted
Hobson, Sue
Tursi, James
Bernstein, Guy
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.3072
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：E682 / E683
页数：2
相关论文
共 50 条
  • [21] Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies REPLY
    Hellstrom, Wayne J. G.
    UROLOGY, 2015, 86 (02) : 299 - 299
  • [22] Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
    Kaufman-Janette, Joely
    Joseph, John H.
    Kaminer, Michael S.
    Clark, James
    Fabi, Sabrina G.
    Gold, Michael H.
    Goldman, Mitchel P.
    Katz, Bruce E.
    Peddy, Kappa
    Schlessinger, Joel
    Young, V. Leroy
    Davis, Matthew
    Hurley, David
    Liu, Genzhou
    McLane, Michael P.
    Vijayan, Saji
    Bass, Lawrence S.
    DERMATOLOGIC SURGERY, 2021, 47 (05) : 649 - 656
  • [23] Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
    Goldman, Mitchel P.
    Sadick, Neil S.
    Young, Leroy
    Kaufman, Gregory J.
    Smith, Ted
    Tursi, James P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB19 - AB19
  • [24] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind clinical study
    Riedl, CR
    Sternig, P
    Langmann, F
    Galle, G
    Engelhardt, PF
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 253 - 254
  • [25] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind clinical study
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 219 - 219
  • [26] Imiquimod 2.5% and 3.75% for the Treatment of Actinic Keratoses:Two Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
    Swanson, Neil
    Smith, Christina Cognata
    Kaur, Mandeep
    Goldenberg, Gary
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (11) : 1278 - 1282
  • [27] Imiquimod 2.5% and 3.75% for the Treatment of Actinic Keratoses: Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
    Swanson, Neil
    Smith, Christina Cognata
    Kaur, Mandeep
    Goldenberg, Gary
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (02) : 166 - 169
  • [28] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind prospective clinical study
    Riedl, CR
    Sternig, P
    Gallé, G
    Langmann, F
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    EUROPEAN UROLOGY, 2005, 48 (04) : 656 - 661
  • [29] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Hayden, Frederick G.
    Lenk, Robert P.
    Stonis, Lucille
    Oldham-Creamer, Catherine
    Kang, Lih Lisa
    Epstein, Carol
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
  • [30] Improvements in symptom severity and daily living with safinamide in Parkinson's disease: a phase III, randomized, double-blind, placebo-controlled study
    Szasz, J.
    Borgohain, R.
    Bhatt, M.
    Rossetti, S.
    Lucini, V.
    Anand, R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S118 - S118
12345